Tang Capital Management as of March 31, 2022
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 53 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Anaptysbio Inc Common (ANAB) | 13.0 | $65M | 2.6M | 24.74 | |
| Intra Cellular Therapies (ITCI) | 8.6 | $43M | 700k | 61.19 | |
| La Jolla Pharmaceuticl Com Par | 8.2 | $41M | 9.6M | 4.27 | |
| Iteos Therapeutics (ITOS) | 6.0 | $30M | 938k | 32.18 | |
| Bio Rad Labs Cl A (BIO) | 4.5 | $23M | 40k | 563.23 | |
| Heron Therapeutics (HRTX) | 4.3 | $21M | 3.7M | 5.72 | |
| Rocket Pharmaceuticals (RCKT) | 4.0 | $20M | 1.3M | 15.86 | |
| Altimmune Com New (ALT) | 3.1 | $16M | 2.6M | 6.09 | |
| Galapagos Nv Spon Adr (GLPG) | 3.1 | $16M | 250k | 62.02 | |
| Harmony Biosciences Hldgs In (HRMY) | 2.9 | $15M | 300k | 48.65 | |
| Albireo Pharma | 2.8 | $14M | 468k | 29.83 | |
| Immunocore Hldgs Ads (IMCR) | 2.3 | $12M | 386k | 29.90 | |
| Coherus Biosciences (CHRS) | 1.9 | $9.7M | 750k | 12.91 | |
| Sierra Oncology Com New | 1.9 | $9.6M | 300k | 32.05 | |
| Kalvista Pharmaceuticals (KALV) | 1.9 | $9.6M | 648k | 14.74 | |
| Inspirato Incorporated Com Cl A | 1.7 | $8.5M | 855k | 9.94 | |
| Tcr2 Therapeutics Inc cs | 1.7 | $8.3M | 3.0M | 2.76 | |
| Allakos (ALLK) | 1.5 | $7.5M | 1.3M | 5.70 | |
| Bluebird Bio (BLUE) | 1.5 | $7.5M | 1.6M | 4.85 | |
| Ionis Pharmaceuticals (IONS) | 1.5 | $7.4M | 200k | 37.04 | |
| ImmunoGen | 1.4 | $7.1M | 1.5M | 4.76 | |
| Enanta Pharmaceuticals (ENTA) | 1.4 | $7.1M | 100k | 71.18 | |
| Biontech Se Sponsored Ads (BNTX) | 1.4 | $6.8M | 40k | 170.55 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $6.3M | 200k | 31.56 | |
| Atyr Pharma Com New (ATYR) | 1.2 | $6.0M | 1.1M | 5.35 | |
| Bioatla (BCAB) | 1.1 | $5.5M | 1.1M | 5.00 | |
| 2seventy Bio Common Stock (TSVT) | 1.0 | $5.1M | 300k | 17.06 | |
| Corvus Pharmaceuticals (CRVS) | 1.0 | $5.1M | 3.1M | 1.64 | |
| Tarsus Pharmaceuticals (TARS) | 1.0 | $5.0M | 300k | 16.82 | |
| Kiniksa Pharmaceuticals Com Cl A | 1.0 | $5.0M | 500k | 9.94 | |
| Genfit S A Ads (GNFT) | 0.9 | $4.7M | 1.2M | 4.00 | |
| Bellus Health Com New | 0.8 | $4.1M | 600k | 6.88 | |
| Vincerx Pharma Com New (VINC) | 0.8 | $4.1M | 1.0M | 4.00 | |
| BRC *w Exp 02/09/2027 | 0.7 | $3.6M | 806k | 4.47 | |
| Tango Therapeutics (TNGX) | 0.7 | $3.6M | 469k | 7.58 | |
| Fortress Biotech | 0.6 | $3.2M | 2.4M | 1.36 | |
| Aslan Pharmaceuticals Ads | 0.6 | $3.0M | 3.3M | 0.90 | |
| Reviva Pharmaceutcls Hldgs I (RVPH) | 0.6 | $3.0M | 1.2M | 2.46 | |
| Nektar Therapeutics Call Call Option | 0.6 | $2.9M | 540k | 5.39 | |
| Nektar Therapeutics Put Put Option | 0.6 | $2.9M | 540k | 5.39 | |
| Vanda Pharmaceuticals (VNDA) | 0.6 | $2.9M | 257k | 11.31 | |
| Biosante Pharmaceuticals (ANIP) | 0.6 | $2.8M | 100k | 28.11 | |
| Inspirato Incorporated *w Exp 02/11/2027 (ISPOW) | 0.5 | $2.7M | 1.4M | 1.94 | |
| Nektar Therapeutics (NKTR) | 0.5 | $2.3M | 430k | 5.39 | |
| Nkarta (NKTX) | 0.5 | $2.3M | 200k | 11.38 | |
| Leap Therapeutics | 0.4 | $2.2M | 1.3M | 1.75 | |
| Equillium (EQ) | 0.4 | $1.9M | 600k | 3.15 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.4 | $1.8M | 50k | 36.34 | |
| Alector (ALEC) | 0.3 | $1.4M | 100k | 14.25 | |
| Tritium Dcfc Ordinary Shares | 0.2 | $1.2M | 124k | 10.04 | |
| Sky Harbour Group Corporatio *w Exp 01/23/2027 (SKYH.WS) | 0.1 | $694k | 460k | 1.51 | |
| Homology Medicines | 0.1 | $653k | 215k | 3.04 | |
| Tscan Therapeutics (TCRX) | 0.1 | $560k | 200k | 2.80 |
